NO20042205L - Transdifferensiering av pankreatiske acinaerceller - Google Patents

Transdifferensiering av pankreatiske acinaerceller

Info

Publication number
NO20042205L
NO20042205L NO20042205A NO20042205A NO20042205L NO 20042205 L NO20042205 L NO 20042205L NO 20042205 A NO20042205 A NO 20042205A NO 20042205 A NO20042205 A NO 20042205A NO 20042205 L NO20042205 L NO 20042205L
Authority
NO
Norway
Prior art keywords
transdifferentiation
acinar cells
pancreatic acinar
pancreatic
cells
Prior art date
Application number
NO20042205A
Other languages
English (en)
Inventor
Lawrence Rosenberg
Original Assignee
Univ Mcgill
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Mcgill filed Critical Univ Mcgill
Publication of NO20042205L publication Critical patent/NO20042205L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0676—Pancreatic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/998—Proteins not provided for elsewhere

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
NO20042205A 2002-01-11 2004-05-28 Transdifferensiering av pankreatiske acinaerceller NO20042205L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34689002P 2002-01-11 2002-01-11
PCT/CA2003/000013 WO2003057862A2 (en) 2002-01-11 2003-01-10 Transdifferentiation of pancreatic acinar cells

Publications (1)

Publication Number Publication Date
NO20042205L true NO20042205L (no) 2004-09-13

Family

ID=23361448

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20042205A NO20042205L (no) 2002-01-11 2004-05-28 Transdifferensiering av pankreatiske acinaerceller

Country Status (20)

Country Link
US (1) US7662768B2 (no)
EP (1) EP1463801B1 (no)
JP (1) JP2005514426A (no)
KR (1) KR20040072680A (no)
CN (1) CN1610693A (no)
AR (1) AR038281A1 (no)
AT (1) ATE404661T1 (no)
AU (1) AU2003201553A1 (no)
BR (1) BR0306656A (no)
CA (1) CA2469052A1 (no)
DE (1) DE60322831D1 (no)
IL (1) IL162749A0 (no)
MA (1) MA27413A1 (no)
MX (1) MXPA04006385A (no)
NO (1) NO20042205L (no)
PE (1) PE20030744A1 (no)
PL (1) PL371260A1 (no)
RU (1) RU2004119417A (no)
TW (1) TW200302228A (no)
WO (1) WO2003057862A2 (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003275853A1 (en) * 2002-10-24 2004-05-13 Mcgill University Use of ingap for reversing diabetes
US20160039877A1 (en) 2013-03-15 2016-02-11 Shenzhen Hightide Biopharmaceutical, Ltd. Compositions and methods of using islet neogenesis peptides and analogs thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0815129B1 (en) * 1995-02-22 2011-01-05 Eastern Virginia Medical School of the Medical College of Hampton Roads Ingap protein involved in pancreatic islet neogenesis
US5834590A (en) * 1995-02-22 1998-11-10 Eastern Virginia Medical School Of The Medical College Of Hampton Roads Ingap protein involved in pancreatic islet neogenesis
CA2463914A1 (en) * 2001-10-18 2003-04-24 Ixion Biotechnology, Inc. Conversion of liver stem and progenitor cells to pancreatic functional cells

Also Published As

Publication number Publication date
PE20030744A1 (es) 2003-10-24
BR0306656A (pt) 2004-10-05
KR20040072680A (ko) 2004-08-18
CN1610693A (zh) 2005-04-27
US20030203850A1 (en) 2003-10-30
AU2003201553A1 (en) 2003-07-24
ATE404661T1 (de) 2008-08-15
AR038281A1 (es) 2005-01-12
DE60322831D1 (de) 2008-09-25
EP1463801A2 (en) 2004-10-06
TW200302228A (en) 2003-08-01
MA27413A1 (fr) 2005-07-01
PL371260A1 (en) 2005-06-13
US7662768B2 (en) 2010-02-16
JP2005514426A (ja) 2005-05-19
WO2003057862A2 (en) 2003-07-17
RU2004119417A (ru) 2005-02-27
IL162749A0 (en) 2005-11-20
CA2469052A1 (en) 2003-07-17
EP1463801B1 (en) 2008-08-13
MXPA04006385A (es) 2004-10-04
WO2003057862A3 (en) 2003-10-02

Similar Documents

Publication Publication Date Title
DK2508521T4 (da) Dimaleat af en aminocrotonylforbindelse og fremgangsmåde til fremstilling deraf
DE60318920D1 (de) Induktion von Insulin-produzierende Zellen
DK1531814T3 (da) Sustained-release tabletkomposition af pramipexol
DK1546122T3 (da) Fremgangsmåde til fremstilling af valsartan
ITTO20030629A1 (it) Procedimento di realizzazione di collegamenti ad
NO20044916L (no) Preparater av sulfinylacetamid
IS7833A (is) Efnasambönd með sameinaða heteróhringi
DE602004026172D1 (de) Optischer detektor der enzymaktivierung
NO20044814L (no) Fremgangsmate for fremstilling av combretastaniner
IS6633A (is) Samsetningar af fínasteríð töflum
NO20042205L (no) Transdifferensiering av pankreatiske acinaerceller
DK1511724T3 (da) Fremgangsmåde til fremstilling af thioalkylaminderivater
DE50202991D1 (de) Hochtemperaturfestes Klebemittel
FI20021110A (fi) Rakennuselementtijärjestely
DK1519936T3 (da) Fremgangsmåde til fremstilling af nevirapin
DK1574493T3 (da) Fremgangsmåde til fremstilling af anthracendiether
UA6909S (uk) Комплект емблем
SE0103468D0 (sv) Stimulering av expansionen av progenitorceller från pankreas
DK1432452T3 (da) Inhibering af STAT-1
ATE556047T1 (de) Kristalline feste form der (2s-5z)-2-amino-7-
UY3316Q (es) Conjunto de panteones
FI20021940A0 (fi) Avoimen rakentamisen tehokkaampi toteuttaminen
FI20021941A0 (fi) Avoimen rakentamisen tehokkaampi toteuttaminen
FI20020510A0 (fi) Siltapilareiden kuorirakenne
FIU20020058U0 (fi) Rakenne-elementti

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application